These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7909335

  • 1. Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.
    Garvey DS, Wasicak JT, Decker MW, Brioni JD, Buckley MJ, Sullivan JP, Carrera GM, Holladay MW, Arneric SP, Williams M.
    J Med Chem; 1994 Apr 15; 37(8):1055-9. PubMed ID: 7909335
    [No Abstract] [Full Text] [Related]

  • 2. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):310-8. PubMed ID: 7518514
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties.
    Lin NH, Gunn DE, Ryther KB, Garvey DS, Donnelly-Roberts DL, Decker MW, Brioni JD, Buckley MJ, Rodrigues AD, Marsh KG, Anderson DJ, Buccafusco JJ, Prendergast MA, Sullivan JP, Williams M, Arneric SP, Holladay MW.
    J Med Chem; 1997 Jan 31; 40(3):385-90. PubMed ID: 9022806
    [Abstract] [Full Text] [Related]

  • 4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT.
    J Pharmacol Exp Ther; 1994 Jul 31; 270(1):319-28. PubMed ID: 7913497
    [Abstract] [Full Text] [Related]

  • 5. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ, Williams M, Pauly JR, Raszkiewicz JL, Campbell JE, Rotert G, Surber B, Thomas SB, Wasicak J, Arneric SP.
    J Pharmacol Exp Ther; 1995 Jun 31; 273(3):1434-41. PubMed ID: 7791118
    [Abstract] [Full Text] [Related]

  • 6. Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties.
    Arneric SP, Sullivan JP, Decker MW, Brioni JD, Bannon AW, Briggs CA, Donnelly-Roberts D, Radek RJ, Marsh KC, Kyncl J.
    Alzheimer Dis Assoc Disord; 1995 Jun 31; 9 Suppl 2():50-61. PubMed ID: 8534424
    [Abstract] [Full Text] [Related]

  • 7. Biochemical characterization of the nicotinic cholinergic receptors in human brain: binding of (-)-[3H]nicotine.
    Shimohama S, Taniguchi T, Fujiwara M, Kameyama M.
    J Neurochem; 1985 Aug 31; 45(2):604-10. PubMed ID: 2861250
    [Abstract] [Full Text] [Related]

  • 8. Application of [125I] (S)-5-iodonicotine, a new radioiodinated ligand, in the assay of nicotinic acetylcholine receptor binding in the brain.
    Saji H, Watanabe A, Kiyono Y, Magata Y, Iida Y, Takaishi Y, Yokoyama A.
    Biol Pharm Bull; 1995 Nov 31; 18(11):1463-6. PubMed ID: 8593459
    [Abstract] [Full Text] [Related]

  • 9. Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.
    Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY.
    Bioorg Med Chem Lett; 1999 Oct 04; 9(19):2795-800. PubMed ID: 10522693
    [Abstract] [Full Text] [Related]

  • 10. Cholinergic deafferentation enhances rat hippocampal pyramidal neuron responsiveness to locally applied nicotine.
    Frazier CJ, Rollins YD, Hall ME, Young DA, Rose GM.
    Brain Res; 1996 Jul 15; 727(1-2):217-20. PubMed ID: 8842401
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I.
    Gattu M, Pauly JR, Boss KL, Summers JB, Buccafusco JJ.
    Brain Res; 1997 Oct 10; 771(1):89-103. PubMed ID: 9383012
    [Abstract] [Full Text] [Related]

  • 12. The role of beta 2-subunit-containing nicotinic acetylcholine receptors in the brain explored with a mutant mouse.
    Léna C, Changeux JP.
    Ann N Y Acad Sci; 1999 Apr 30; 868():611-6. PubMed ID: 10414341
    [Abstract] [Full Text] [Related]

  • 13. In vivo labeling of nicotinic cholinergic receptors in brain with [3H]cytisine.
    Flesher JE, Scheffel U, London ED, Frost JJ.
    Life Sci; 1994 Apr 30; 54(24):1883-90. PubMed ID: 8196506
    [Abstract] [Full Text] [Related]

  • 14. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM, Yaksh TL, Taylor P.
    J Pharmacol Exp Ther; 1994 Jul 30; 270(1):159-66. PubMed ID: 8035312
    [Abstract] [Full Text] [Related]

  • 15. Nicotine and alpha-bungarotoxin binding to axonal and non-neural tissues.
    Jones SW, Galasso RT, O'Brien RD.
    J Neurochem; 1977 Nov 30; 29(5):803-9. PubMed ID: 591957
    [No Abstract] [Full Text] [Related]

  • 16. Identification and functional significance of nicotinic cholinergic receptors in the rat pineal gland.
    Stankov B, Cimino M, Marini P, Lucini V, Fraschini F, Clementi F.
    Neurosci Lett; 1993 Jun 25; 156(1-2):131-4. PubMed ID: 8414175
    [Abstract] [Full Text] [Related]

  • 17. Alcohol preference: association with reduced striatal nicotinic receptors.
    Tizabi Y, Getachew B, Davila-Garcia M, Taylor RE.
    Alcohol Alcohol; 2001 Jun 25; 36(4):318-22. PubMed ID: 11468132
    [Abstract] [Full Text] [Related]

  • 18. Effects of chronic treatment with (+)-nicotine on the stress-induced hypertension and downregulation of central nicotinic receptors in rats: comparative study with (-)-nicotine.
    Takita M, Taniguchi T, Zhu J, Piao HL, Tsai TY, Muramatsu I.
    Gen Pharmacol; 1999 Jul 25; 33(1):29-33. PubMed ID: 10428013
    [Abstract] [Full Text] [Related]

  • 19. Binding of alpha-[125I]bungarotoxin to a particulate fraction of toad brain.
    Oswald RE, Freeman JA.
    Brain Res; 1981 Aug 10; 218(1-2):406-11. PubMed ID: 6791764
    [No Abstract] [Full Text] [Related]

  • 20. [3H]acetylcholine nicotinic recognition sites in human brain: characterization of agonist binding.
    Adem A, Synnergren B, Botros M, Ohman B, Winblad B, Nordberg A.
    Neurosci Lett; 1987 Dec 29; 83(3):298-302. PubMed ID: 3441312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.